GLPQ; B. miyamotoi
Back to Test Catalogue
Borrelia miyamotoi Antibodies (IgG and IgM), Serum
Test ID: BORMIYGM S
Test
Aliases/Synonyms
Method
Immunoassay
Report Includes
B. miyamotoi Ab (IgG); B. miyamotoi Ab (IgM)
Specimens
Serum
Clinical Utility
Borrelia miyamotoi is a tick-borne bacterial organism that causes a nonspecific febrile illness that may be misdiagnosed as Lyme disease or other tick-borne infections. Positive antibody results suggest B. miyamotoi infection; however, other tick-borne organisms may induce cross-reactive antibodies. Negative IgG and IgM results do not exclude the possibility of B. miyamotoi infection.
Test Location
Quest Diagnostics, California USA
Test Version
18-Aug-2023
Specimen
Specimens
Serum
Collection Containers
Gold top (clot activator & gel)
Sample Volume
1.5 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | 7 days |
|---|---|
| Refrigerated | 14 days |
| Frozen | 30 days |
Rejection Criteria
| Hemolysis | Gross |
|---|---|
| Lipemia | Gross |
| Icterus | Gross |
Test Version
18-Aug-2023
Performance / Interpretation
Method
Immunoassay
Turnaround Time
7 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| B. miyamotoi Ab (IgG) | Index |
|
||
| B. miyamotoi Ab (IgM) | Index |
|
||
Test Location
Quest Diagnostics, California USA
Test Version
18-Aug-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| BORMIYGM S | 65183B. MIYAMOTOI AB (IGG) | INDEX |
| 65184B. MIYAMOTOI AB (IGM) | INDEX | |
| 65185INTERPRETATION |
Test Version
18-Aug-2023